Give now

News

  • September 30, 2022
    Influencer Meredith Staggers Says Her Migraine Turned Out to Be a Life-Threatening Brain Aneurysm
    Learn more
  • September 21, 2022
    Meet Research Grant Recipient: Nicholas Norris
    Learn more
  • September 13, 2022
    1 in 4 Adults in the U.S. Lives with a Disability. Having a Financial Plan to Address Care is Critical
    Learn more
  • September 08, 2022
    Life After a Brain Aneurysm, A Survivor’s Story
    Learn more
  • September 08, 2022
    Meet Research Grant Recipient: Devin McBride, PhD
    Learn more
  • September 01, 2022
    Meet Research Grant Recipient: Melanie Martinez
    Learn more
  • August 30, 2022
    Meet Research Grant Recipient: Mark Johnson, MD
    Learn more
  • August 25, 2022
    Meet Research Grant Recipient: Koji Hosaka, PhD
    Learn more
  • August 24, 2022
    Meet Research Grant Recipient: Louis-Philippe Bernier, PhD
    Learn more
  • August 16, 2022
    Meet Research Grant Recipient: Umeshkumar Athiraman, MD, MBBS
    Learn more

In My Area

Support groups
  • AdventHealth Brain Aneurysm Support Group

    Winter Park, FL

    Learn more
  • Baltimore Brain Aneurysm Foundation Support Group

    Lutherville-Timonium, MD

    Learn more
  • Bay Area Aneurysm and Vascular Malformation Support Group

    San Francisco, CA

    Learn more
  • August 24, 2022
  • BAF
  • Awareness
  • Technology

Meet Research Grant Recipient: Louis-Philippe Bernier, PhD

Louis-Philippe Bernier, PhD, is a research associate at the University of British Columbia, in Vancouver BC, previously having completed his PhD in Neuroscience at McGill University. Dr. Bernier  has been studying the mechanisms of cerebrovascular control for 10 years, focusing on how neuroinflammation affects blood flow in the brain.

Dr. Bernier is studying a novel molecular pathway that is believed to drive the pathological tightening of blood vessels in the brain that often occurs in the days following brain aneurysm rupture. 

Dr. Bernier is the recipient of the Brain Aneurysm Foundation Chair of Research for $30,000. He hopes that by identifying a new pathway that drives pathological constriction of blood vessels, his team will be able to block this molecular pathway using therapeutic agents. Since the pathological vasospasms that are studied occur several days after the initial aneurysm rupture, a drug therapy could potentially be given during that time window.



This site uses cookies

Our site uses cookies to personalize features and, via third-parties, to collect metrics on usage so that we can better tailor our site to the needs of our users. You can view our full cookie and privacy policies via the links below. To fully experience our site, please click Accept.